(Q42650503)

4 November 2017

title

Treatment considerations for persons with metastatic prostate cancer: survival versus out-of-pocket costs (English)

1 reference

4 November 2017

1

1 reference

4 November 2017

McCrory DC

2

1 reference

4 November 2017

Bennett CL

series ordinal

3

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

4 November 2017

1 reference

4 November 2017

volume

49

1 reference

4 November 2017

issue

2

1 reference

4 November 2017

page(s)

218-224

1 reference

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

Estimating the cost effectiveness of total androgen blockade with flutamide in M1 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

Methods for quality adjustment of life years

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2896%2900434-7

7 January 2021

10.1016/S0090-4295(96)00434-7

Identifiers

DOI

1 reference

4 November 2017

1 reference